The drug makers are committing. Europe is waiting

22-10-2026

NEXXAHEALTH - For years, Europe's low medicine prices and its patchwork of national markets were things it could live with. America's new pricing rules has turned both against it. Bas Amesz, who a decade ago proposed a different way to pay for medicines, argues the shock is Europe's chance to buy innovation as a single bloc, and that its instinct to wait is the real danger. Read more

Photo: White House - MOLLY RILEY



     

    Share